(EWCZ) European Wax Center - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US29882P1066
Stock: Waxing, Serums, Exfoliators, Skincare, Retail
Total Rating 24
Risk 76
Buy Signal -0.47
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 58.6% |
| Relative Tail Risk | -8.94% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.51 |
| Alpha | -62.10 |
| Character TTM | |
|---|---|
| Beta | 1.596 |
| Beta Downside | 1.011 |
| Drawdowns 3y | |
|---|---|
| Max DD | 84.28% |
| CAGR/Max DD | -0.47 |
Description: EWCZ European Wax Center December 31, 2025
European Wax Center, Inc. (NASDAQ:EWCZ) is a U.S.–based franchisor and operator that provides in-person waxing services for body and face, complemented by a retail line of post-treatment products such as ingrown-hair serums, exfoliating gels, and skin-care items. Founded in 2004 and headquartered in Plano, Texas, the company positions itself within the Specialized Consumer Services sub-industry.
Key metrics as of the latest filing show approximately 800 locations nationwide, with FY 2023 revenue of $453 million and a 12% year-over-year increase in same-store sales, reflecting strong consumer demand for personal-care services despite modest discretionary-spending headwinds. The franchise model drives scalable growth, while the broader beauty-and-personal-care sector benefits from rising “self-care” spending and a post-pandemic shift toward localized, experience-based services.
For a deeper dive into how these trends translate into valuation outlooks, consider exploring ValueRay’s analyst notes on EWCZ.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 11.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.27 > 1.0 |
| NWC/Revenue: 37.37% < 20% (prev 26.79%; Δ 10.58% < -1%) |
| CFO/TA 0.09 > 3% & CFO 61.8m > Net Income 11.2m |
| Net Debt (308.6m) to EBITDA (66.6m): 4.64 < 3 |
| Current Ratio: 3.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.5m) vs 12m ago -6.25% < -2% |
| Gross Margin: 69.36% > 18% (prev 0.73%; Δ 6863 % > 0.5%) |
| Asset Turnover: 29.58% > 50% (prev 31.57%; Δ -1.99% > 0%) |
| Interest Coverage Ratio: 1.78 > 6 (EBITDA TTM 66.6m / Interest Expense TTM 26.2m) |
Altman Z'' 0.44
| A: 0.11 (Total Current Assets 108.5m - Total Current Liabilities 29.6m) / Total Assets 720.7m |
| B: -0.13 (Retained Earnings -91.1m / Total Assets 720.7m) |
| C: 0.07 (EBIT TTM 46.5m / Avg Total Assets 714.3m) |
| D: -0.29 (Book Value of Equity -177.4m / Total Liabilities 615.9m) |
| Altman-Z'' Score: 0.44 = B |
Beneish M -3.07
| DSRI: 1.05 (Receivables 7.09m/7.14m, Revenue 211.3m/223.5m) |
| GMI: 1.05 (GM 69.36% / 73.11%) |
| AQI: 0.96 (AQ_t 0.83 / AQ_t-1 0.87) |
| SGI: 0.95 (Revenue 211.3m / 223.5m) |
| TATA: -0.07 (NI 11.2m - CFO 61.8m) / TA 720.7m) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of EWCZ shares?
As of February 07, 2026, the stock is trading at USD 4.03 with a total of 293,178 shares traded.
Over the past week, the price has changed by +2.54%, over one month by +0.25%, over three months by +9.21% and over the past year by -40.65%.
Over the past week, the price has changed by +2.54%, over one month by +0.25%, over three months by +9.21% and over the past year by -40.65%.
Is EWCZ a buy, sell or hold?
European Wax Center has received a consensus analysts rating of 3.50.
Therefor, it is recommend to hold EWCZ.
- StrongBuy: 3
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the EWCZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.6 | 64.8% |
| Analysts Target Price | 6.6 | 64.8% |
| ValueRay Target Price | 2.8 | -30.5% |
EWCZ Fundamental Data Overview February 03, 2026
P/E Trailing = 15.1154
P/S = 1.0334
P/B = 2.1984
Revenue TTM = 211.3m USD
EBIT TTM = 46.5m USD
EBITDA TTM = 66.6m USD
Long Term Debt = 374.4m USD (from longTermDebt, last quarter)
Short Term Debt = 5.22m USD (from shortTermDebt, last quarter)
Debt = 382.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 308.6m USD (from netDebt column, last quarter)
Enterprise Value = 526.9m USD (218.3m + Debt 382.2m - CCE 73.6m)
Interest Coverage Ratio = 1.78 (Ebit TTM 46.5m / Interest Expense TTM 26.2m)
EV/FCF = 8.88x (Enterprise Value 526.9m / FCF TTM 59.3m)
FCF Yield = 11.26% (FCF TTM 59.3m / Enterprise Value 526.9m)
FCF Margin = 28.09% (FCF TTM 59.3m / Revenue TTM 211.3m)
Net Margin = 5.32% (Net Income TTM 11.2m / Revenue TTM 211.3m)
Gross Margin = 69.36% ((Revenue TTM 211.3m - Cost of Revenue TTM 64.7m) / Revenue TTM)
Gross Margin QoQ = 63.98% (prev 65.70%)
Tobins Q-Ratio = 0.73 (Enterprise Value 526.9m / Total Assets 720.7m)
Interest Expense / Debt = 1.71% (Interest Expense 6.52m / Debt 382.2m)
Taxrate = 27.36% (2.02m / 7.39m)
NOPAT = 33.8m (EBIT 46.5m * (1 - 27.36%))
Current Ratio = 3.67 (Total Current Assets 108.5m / Total Current Liabilities 29.6m)
Debt / Equity = 4.89 (Debt 382.2m / totalStockholderEquity, last quarter 78.1m)
Debt / EBITDA = 4.64 (Net Debt 308.6m / EBITDA 66.6m)
Debt / FCF = 5.20 (Net Debt 308.6m / FCF TTM 59.3m)
Total Stockholder Equity = 72.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.57% (Net Income 11.2m / Total Assets 720.7m)
RoE = 15.55% (Net Income TTM 11.2m / Total Stockholder Equity 72.3m)
RoCE = 10.41% (EBIT 46.5m / Capital Employed (Equity 72.3m + L.T.Debt 374.4m))
RoIC = 7.50% (NOPAT 33.8m / Invested Capital 450.1m)
WACC = 5.08% (E(218.3m)/V(600.5m) * Re(11.79%) + D(382.2m)/V(600.5m) * Rd(1.71%) * (1-Tc(0.27)))
Discount Rate = 11.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -7.88%
[DCF Debug] Terminal Value 86.74% ; FCFF base≈58.2m ; Y1≈60.6m ; Y5≈69.7m
Fair Price DCF = 40.29 (EV 2.07b - Net Debt 308.6m = Equity 1.76b / Shares 43.7m; r=5.90% [WACC]; 5y FCF grow 4.46% → 2.90% )
EPS Correlation: -44.27 | EPS CAGR: -55.12% | SUE: -2.46 | # QB: 0
Revenue Correlation: 42.77 | Revenue CAGR: 5.01% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.14 | Chg30d=-0.045 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-12-31): EPS=0.55 | Chg30d=-0.009 | Revisions Net=+1 | Growth EPS=+1.5% | Growth Revenue=+1.6%
P/S = 1.0334
P/B = 2.1984
Revenue TTM = 211.3m USD
EBIT TTM = 46.5m USD
EBITDA TTM = 66.6m USD
Long Term Debt = 374.4m USD (from longTermDebt, last quarter)
Short Term Debt = 5.22m USD (from shortTermDebt, last quarter)
Debt = 382.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 308.6m USD (from netDebt column, last quarter)
Enterprise Value = 526.9m USD (218.3m + Debt 382.2m - CCE 73.6m)
Interest Coverage Ratio = 1.78 (Ebit TTM 46.5m / Interest Expense TTM 26.2m)
EV/FCF = 8.88x (Enterprise Value 526.9m / FCF TTM 59.3m)
FCF Yield = 11.26% (FCF TTM 59.3m / Enterprise Value 526.9m)
FCF Margin = 28.09% (FCF TTM 59.3m / Revenue TTM 211.3m)
Net Margin = 5.32% (Net Income TTM 11.2m / Revenue TTM 211.3m)
Gross Margin = 69.36% ((Revenue TTM 211.3m - Cost of Revenue TTM 64.7m) / Revenue TTM)
Gross Margin QoQ = 63.98% (prev 65.70%)
Tobins Q-Ratio = 0.73 (Enterprise Value 526.9m / Total Assets 720.7m)
Interest Expense / Debt = 1.71% (Interest Expense 6.52m / Debt 382.2m)
Taxrate = 27.36% (2.02m / 7.39m)
NOPAT = 33.8m (EBIT 46.5m * (1 - 27.36%))
Current Ratio = 3.67 (Total Current Assets 108.5m / Total Current Liabilities 29.6m)
Debt / Equity = 4.89 (Debt 382.2m / totalStockholderEquity, last quarter 78.1m)
Debt / EBITDA = 4.64 (Net Debt 308.6m / EBITDA 66.6m)
Debt / FCF = 5.20 (Net Debt 308.6m / FCF TTM 59.3m)
Total Stockholder Equity = 72.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.57% (Net Income 11.2m / Total Assets 720.7m)
RoE = 15.55% (Net Income TTM 11.2m / Total Stockholder Equity 72.3m)
RoCE = 10.41% (EBIT 46.5m / Capital Employed (Equity 72.3m + L.T.Debt 374.4m))
RoIC = 7.50% (NOPAT 33.8m / Invested Capital 450.1m)
WACC = 5.08% (E(218.3m)/V(600.5m) * Re(11.79%) + D(382.2m)/V(600.5m) * Rd(1.71%) * (1-Tc(0.27)))
Discount Rate = 11.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -7.88%
[DCF Debug] Terminal Value 86.74% ; FCFF base≈58.2m ; Y1≈60.6m ; Y5≈69.7m
Fair Price DCF = 40.29 (EV 2.07b - Net Debt 308.6m = Equity 1.76b / Shares 43.7m; r=5.90% [WACC]; 5y FCF grow 4.46% → 2.90% )
EPS Correlation: -44.27 | EPS CAGR: -55.12% | SUE: -2.46 | # QB: 0
Revenue Correlation: 42.77 | Revenue CAGR: 5.01% | SUE: 1.05 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.14 | Chg30d=-0.045 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-12-31): EPS=0.55 | Chg30d=-0.009 | Revisions Net=+1 | Growth EPS=+1.5% | Growth Revenue=+1.6%